Comparison between Star Health IPO and Tarsons Products IPO.
Star Health IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Tarsons Products IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Star Health IPO is up to ₹6,018.68 Cr whereas the issue size of the Tarsons Products IPO is up to ₹1,023.54 Cr. The final issue price of Star Health IPO is ₹900.00 per share and of Tarsons Products IPO is ₹662.00 per share.
| Star Health IPO | Tarsons Products IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹870.00 per share | ₹635.00 per share |
| Issue Price (Upper) | ₹900.00 per share | ₹662.00 per share |
| Issue Price (Final) | ₹900.00 per share | ₹662.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹80.00 per share | ₹61.00 per share |
| Market Lot Size | 16 shares | 22 shares |
| Fresh Issue Size | 2,22,32,230 shares | 22,65,862 shares |
| Fresh Issue Size (Amount) | up to ₹2,000.66 Cr | up to ₹149.96 Cr |
| OFS Issue Size | 4,46,50,231 shares | 1,31,99,999 shares |
| OFS Issue Size (Amount) | up to ₹4,018.03 Cr | up to ₹873.58 Cr |
| Issue Size Total | 6,68,82,461 shares | 1,54,65,861 shares |
| Issue Size Total (Amount) | up to ₹6,018.68 Cr | up to ₹1,023.54 Cr |
Star Health IPO opens on Nov 30, 2021, while Tarsons Products IPO opens on Nov 15, 2021. The closing date of Star Health IPO and Tarsons Products IPO is Dec 02, 2021, and Nov 17, 2021, respectively.
| Star Health IPO | Tarsons Products IPO | |
|---|---|---|
| Anchor Bid Date | Nov 29, 2021 | Nov 12, 2021 |
| Issue Open | Nov 30, 2021 | Nov 15, 2021 |
| Issue Close | Dec 02, 2021 | Nov 17, 2021 |
| Basis Of Allotment (Tentative) | Dec 07, 2021 | Nov 23, 2021 |
| Initiation of Refunds (Tentative) | Dec 08, 2021 | Nov 24, 2021 |
| Credit of Share (Tentative) | Dec 09, 2021 | Nov 25, 2021 |
| Listing date (Tentative) | Dec 10, 2021 | Nov 26, 2021 |
| Anchor Lockin End date 1 | Jan 06, 2022 | Dec 23, 2021 |
| Anchor Lockin End date 2 | Mar 07, 2022 | Feb 21, 2022 |
Star Health IPO P/E ratio is , as compared to Tarsons Products IPO P/E ratio of .
| Star Health IPO | Tarsons Products IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 66.22 | 50.75 | ||||
| Promoter Shareholding (Post-Issue) | 58.42 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹51797.00 Cr. | ₹3522.26 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Star Health IPO Retail Individual Investors (RII) are offered 85,06,656 shares while in Tarsons Products IPO retail investors are offered 85,06,656 shares. Qualified Institutional Buyers (QIB) are offered 2,44,93,456 shares in Star Health IPO and 30,81,172 shares in Tarsons Products IPO.
| Star Health IPO | Tarsons Products IPO | |
|---|---|---|
| Anchor Investor Reservation | 3,57,45,901 shares | 46,21,757 shares |
| Market Maker Reservation | ||
| QIB | 2,44,93,456 shares | 30,81,172 shares |
| NII | 22,67,392 shares | 23,10,880 shares |
| RII | 85,06,656 shares | 53,92,052 shares |
| Employee | 1,12,592 shares | 60,000 shares |
| Others | ||
| Total | 7,11,25,997 shares | 1,54,65,861 shares |
Star Health IPO subscribed 0.79x in total, whereas Tarsons Products IPO subscribed 77.49x.
| Star Health IPO | Tarsons Products IPO | |
|---|---|---|
| QIB (times) | 1.03x | 115.77x |
| NII (times) | 0.19x | 184.58x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.10x | 10.56x |
| Employee (times) | 0.10x | 1.83x |
| Other (times) | ||
| Total (times) | 0.79x | 77.49x |
